Clinical Trial: A multicenter retrospective observational study of real-world T-DXd treatment for stage4 HER2-mutated non-small cell lung cancer patients in Japan (REAL-HER2 Study) (WJOG21224L) (Japan)

Tokyo, Sept. 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059178) titled 'A multicenter retrospective observational study of real-world T-DXd treatment for stage4 HER2-mutated non-small cell lung cancer patients in Japan (REAL-HER2 Study) (WJOG21224L)' on Sept. 25.

Study Type: Observational

Primary Sponsor: Institute - West Japan Oncology Group

Condition: Condition - Lung Cancer Classification by malignancy - Malignancy Genomic information - YES

Objective: Narrative objectives1 - To investigate real-world treatment patterns in previously treated patients with stage IV HER2-mutant non-small cell lung cancer (NSCLC) in Japan, and to assess the effectiveness and safety of trastuzumab der...